AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe...

cafead

Administrator
Staff member
  • cafead   Dec 17, 2019 at 10:32: AM
via AstraZeneca has completed an agreement to divest its commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe and Russia to Cheplapharm Arzneimittel GmbH (Cheplapharm).

article source